- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 9, 2025 | 27.35M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $68.74M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $70M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $49.74M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $62.61M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $54.63M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $69.36M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $85.76M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $107.12M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $106.22M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $127.85M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 31.6M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 31.86M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $8.53M |
| Capex | Q3 2025 · Mar 31, 2024 | $149K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $17.57M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $63.86M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $66.79M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $61.7M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.05 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.20 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.05 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.20 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $2.45M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $8.03M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $6.66M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $19.95M |
| Net Income | Q3 2025 · Mar 31, 2024 | $1.49M |
| Net Income | Q3 2025 · Mar 31, 2024 | $6.27M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $938K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $4.78M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $15.49M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $49.66M |
| Revenue | Q3 2025 · Mar 31, 2024 | $22.35M |
| Revenue | Q3 2025 · Mar 31, 2024 | $70.34M |